143 related articles for article (PubMed ID: 12684293)
1. The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD.
Domagała-Kulawik J; Maskey-Warzechowska M; Kraszewska I; Chazan R
Chest; 2003 Apr; 123(4):1054-9. PubMed ID: 12684293
[TBL] [Abstract][Full Text] [Related]
2. Expression of macrophage surface markers in induced sputum of patients with chronic obstructive pulmonary disease.
Domagała-Kulawik J; Maskey-Warzechowska M; Hermanowicz-Salamon J; Chazan R
J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():75-84. PubMed ID: 17072032
[TBL] [Abstract][Full Text] [Related]
3. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD.
Kunz LI; Lapperre TS; Snoeck-Stroband JB; Budulac SE; Timens W; van Wijngaarden S; Schrumpf JA; Rabe KF; Postma DS; Sterk PJ; Hiemstra PS;
Respir Res; 2011 Mar; 12(1):34. PubMed ID: 21426578
[TBL] [Abstract][Full Text] [Related]
4. Decreased sputum mature dendritic cells in healthy smokers and patients with chronic obstructive pulmonary disease.
Tsoumakidou M; Bouloukaki I; Koutala H; Kouvidi K; Mitrouska I; Zakynthinos S; Tzanakis N; Jeffery PK; Siafakas NM
Int Arch Allergy Immunol; 2009; 150(4):389-97. PubMed ID: 19571571
[TBL] [Abstract][Full Text] [Related]
5. Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD.
Wen Y; Reid DW; Zhang D; Ward C; Wood-Baker R; Walters EH
Int J Chron Obstruct Pulmon Dis; 2010 Oct; 5():327-34. PubMed ID: 21037956
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte counts and macrophage phenotypes in induced sputum and bronchoalveolar lavage fluid from normal subjects.
Lensmar C; Elmberger G; Sandgren P; Sköld CM; Eklund A
Eur Respir J; 1998 Sep; 12(3):595-600. PubMed ID: 9762786
[TBL] [Abstract][Full Text] [Related]
8. [Macrophage phenotype in induced sputum in asthma subjects].
Hermanowicz-Salamon J; Domagała-Kulawik J; Maskey-Warzechowska M; Chazan R
Pneumonol Alergol Pol; 2006; 74(1):101-5. PubMed ID: 17175987
[TBL] [Abstract][Full Text] [Related]
9. [The clinical characteristics of intra-acinar pulmonary artery inflammation and its effect on clinical parameters in smokers with normal lung function and patients with chronic obstructive pulmonary disease].
Lao QF; Zhong XN; He ZY; Liu GN; Lü ZL; Wan P
Zhonghua Nei Ke Za Zhi; 2011 Oct; 50(10):839-44. PubMed ID: 22321324
[TBL] [Abstract][Full Text] [Related]
10. Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD.
Babusyte A; Stravinskaite K; Jeroch J; Lötvall J; Sakalauskas R; Sitkauskiene B
Respir Res; 2007 Nov; 8(1):81. PubMed ID: 18001475
[TBL] [Abstract][Full Text] [Related]
11. Relation between duration of smoking cessation and bronchial inflammation in COPD.
Lapperre TS; Postma DS; Gosman MM; Snoeck-Stroband JB; ten Hacken NH; Hiemstra PS; Timens W; Sterk PJ; Mauad T
Thorax; 2006 Feb; 61(2):115-21. PubMed ID: 16055612
[TBL] [Abstract][Full Text] [Related]
12. Airway inflammation and cellular stress in noneosinophilic atopic asthma.
Tsoumakidou M; Papadopouli E; Tzanakis N; Siafakas NM
Chest; 2006 May; 129(5):1194-202. PubMed ID: 16685009
[TBL] [Abstract][Full Text] [Related]
13. Eosinophils in induced sputum from asymptomatic smokers with normal lung function.
Dippolito R; Foresi A; Chetta A; Castagnaro A; Malorgio R; Marangio E; Olivieri D
Respir Med; 2001 Dec; 95(12):969-74. PubMed ID: 11778794
[TBL] [Abstract][Full Text] [Related]
14. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.
Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I
Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622
[TBL] [Abstract][Full Text] [Related]
15. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease.
Hodge S; Hodge G; Ahern J; Jersmann H; Holmes M; Reynolds PN
Am J Respir Cell Mol Biol; 2007 Dec; 37(6):748-55. PubMed ID: 17630319
[TBL] [Abstract][Full Text] [Related]
16. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers.
Löfdahl JM; Wahlström J; Sköld CM
Clin Exp Immunol; 2006 Sep; 145(3):428-37. PubMed ID: 16907910
[TBL] [Abstract][Full Text] [Related]
17. Induced sputum and peripheral blood cell profile in chronic obstructive pulmonary disease.
Rufino R; Costa CH; Souza HS; Madi K; Silva JR
J Bras Pneumol; 2007; 33(5):510-8. PubMed ID: 18026648
[TBL] [Abstract][Full Text] [Related]
18. Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis.
Gamble E; Grootendorst DC; Hattotuwa K; O'Shaughnessy T; Ram FS; Qiu Y; Zhu J; Vignola AM; Kroegel C; Morell F; Pavord ID; Rabe KF; Jeffery PK; Barnes NC
Eur Respir J; 2007 Sep; 30(3):467-71. PubMed ID: 17504799
[TBL] [Abstract][Full Text] [Related]
19. [The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease].
Wan P; Zhong XN; He ZY; Zhang JQ; Liu GN; Lao QF
Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):841-5. PubMed ID: 20079227
[TBL] [Abstract][Full Text] [Related]
20. Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD.
Willemse BW; ten Hacken NH; Rutgers B; Lesman-Leegte IG; Timens W; Postma DS
Eur Respir J; 2004 Sep; 24(3):391-6. PubMed ID: 15358697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
